Exolitus UAB is a biotech startup dedicated to advancing pharmaceutical development through the exploration of vesicular and non-vesicular extracellular particles. Leveraging a variety of cell culture sources across animal, plant, and fungal kingdoms, we produce extracellular particles with targeted therapeutic properties. These properties are further refined through cell instruction, selective extracellular particle population engineering, and innovative modification techniques. Our mission is to harness the power of extracellular particles to create multi-pathway medicines based on cellular communication, paving the way for novel healthcare solutions.
